Dr. Matthew Campbell, MD
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Studies Bladder Cancer
Studies Rhabdomyosarcoma
19 reported clinical trials
36 drugs studied
Area of expertise
1Bladder Cancer
Stage III
HER2 positive
Stage IV
2Rhabdomyosarcoma
PD-L1 positive
Stage IV
FOXO1 fusion negative
Affiliated Hospitals
Clinical Trials Matthew Campbell, MD is currently running
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
Abemaciclib + Temozolomide
for Brain Tumors
The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.
Recruiting1 award Phase 26 criteria
More about Matthew Campbell, MD
Clinical Trial Related3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Matthew Campbell, MD has experience with
- Cyclophosphamide
- Dactinomycin
- Cisplatin
- Doxorubicin Hydrochloride
- Methotrexate
- Cabozantinib
Breakdown of trials Matthew Campbell, MD has run
Bladder Cancer
Rhabdomyosarcoma
Osteosarcoma
Embryonal Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Campbell, MD specialize in?
Matthew Campbell, MD focuses on Bladder Cancer and Rhabdomyosarcoma. In particular, much of their work with Bladder Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Matthew Campbell, MD currently recruiting for clinical trials?
Yes, Matthew Campbell, MD is currently recruiting for 10 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Matthew Campbell, MD has studied deeply?
Yes, Matthew Campbell, MD has studied treatments such as Cyclophosphamide, Dactinomycin, Cisplatin.
What is the best way to schedule an appointment with Matthew Campbell, MD?
Apply for one of the trials that Matthew Campbell, MD is conducting.
What is the office address of Matthew Campbell, MD?
The office of Matthew Campbell, MD is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.